Physician profile
Komal Chandan
NPI 1508896457
$729.85
in general payments reported to CMS, 2019-2025
16 companies · $23.42 in 2025
The $23.42 reported for 2025 was less than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.86 · 2020: $233 · 2021: $161 · 2022: $177 · 2023: $48.13 · 2025: $23.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $71.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $71.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $256.05 | 2020-2022 | |
| Lilly USA, LLC | $77.78 | 2020-2023 | Jardiance, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.23 | 2019-2022 | |
| Novo Nordisk INC | $46.00 | 2020-2021 | |
| Glaxosmithkline, LLC. | $41.29 | 2020-2023 | Arexvy, Shingrix |
| Amgen INC. | $40.73 | 2020-2021 | |
| Pfizer INC. | $34.78 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $32.46 | 2019-2021 | |
| Amarin Pharma, INC. | $26.89 | 2020 | |
| Novartis Pharmaceuticals Corporation | $23.42 | 2025 | |
| Sunovion Pharmaceuticals INC. | $21.15 | 2019 | |
| Esperion Therapeutics, INC. | $17.13 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.46 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.13 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.24 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Komal Chandan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.